InChI=1S/C25H44NO11P/c1-2-3-6-9-19(35-29)12-13-22-21(23-16-24(22)37-36-23)10-7-4-5-8-11-25(28)34-20(17-27)18-33-38(30,31)32-15-14-26/h4,7,12-13,19-24,27,29H,2-3,5-6,8-11,14-18,26H2,1H3,(H,30,31)/b7-4-,13-12+/t19-,20+,21+,22+,23-,24+/m0/s1 |
GARJYNYOLGHMOP-GONZANLZSA-N |
P(=O)([O-])(OCC[NH3+])OC[C@@H](CO)OC(CCC/C=C\C[C@H]1[C@@H]2C[C@H]([C@@H]1/C=C/[C@H](CCCCC)OO)OO2)=O |
|
Outgoing
|
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:138098)
is a
2-acyl-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:65213)
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:138098)
is a
oxidized 2-acyl-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:167121)
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:138098)
is tautomer of
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:138744)
|
|
Incoming
|
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine
(CHEBI:138744)
is tautomer of
2-[(9S,11R)-epidioxy-(15S)-hydroperoxy-(5Z,13E)-prostadienoyl]-sn-glycero-3-phosphoethanolamine zwitterion
(CHEBI:138098)
|
2-azaniumylethyl (2R)-2-{[(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3-hydroperoxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl}hept-5-enoyl]oxy}-3-hydroxypropyl phosphate
|
2-(prostaglandin G2)-LPE zwitterion
|
ChEBI
|
2-(prostaglandin G2)-sn-glycero-3-phosphoethanolamine
|
UniProt
|
2-(prostaglandin G2)-sn-glycero-3-phosphoethanolamine zwitterion
|
SUBMITTER
|
27642067
|
PubMed citation
|
SUBMITTER
|
|